查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1963825

光声成像市场－全球产业规模、份额、趋势、机会与预测：按产品、类型、应用、地区和竞争对手划分，2021-2031年

Photoacoustic Imaging Market - Global Industry Size, Share, Trends, Opportunity & Forecast, Segmented By Product (Photoacoustic Tomography, Photoacoustic Microscopy ), By Type, By Application, By Region & Competition, 2021-2031F
出版日期: | 出版商: TechSci Research | 英文 180 Pages | 商品交期: 2-3个工作天内

价格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

简介目录

全球光声成像市场预计将从 2025 年的 8,428 万美元成长到 2031 年的 1.5351 亿美元，复合年增长率为 10.51%。

作为一种混合生物医学技术，它利用光声效应，结合了光学成像的高对比和超音波的深层组织穿透能力。该领域的发展主要受慢性疾病（尤其是癌症和心血管疾病）日益普遍的推动。这些疾病需要能够进行功能性影像的非侵入性诊断方法。该技术无需使用电离辐射即可绘製血氧饱和度和血红蛋白水平图，进一步加剧了这项需求。鑑于美国癌症协会预测2024年美国将新增2,001,140例癌症病例，这项技术显得格外重要。

市场概览
预测期 2027-2031
市场规模：2025年 8428万美元
市场规模：2031年 1.5351亿美元
复合年增长率：2026-2031年 10.51%
成长最快的细分市场 光声成像（PAT）
最大的市场 北美洲

儘管存在这些市场驱动因素，但由于设备高成本以及系统操作所需的技术复杂性，市场成长仍面临许多挑战。这些双模态系统所需的大量资本投入造成了财务壁垒，使得采购主要局限于大型研究机构，而小规模临床机构则被排除在外。此外，目前尚无针对光声成像程序的既定报销代码，这限制了该技术融入标准临床工作流程，从而阻碍了其商业性化应用。

市场驱动因素

高解析度混合成像系统的技术突破正在推动其快速发展，克服了扫描速度和影像品质的传统限制。雷射技术和超音波换能器的进步使得设备能够以卓越的清晰度提供即时功能性资讯。例如，2024年9月，伦敦大学学院的研究人员开发了一种手持式扫描仪，其生成精细三维光声影像的速度比以往型号快100到1000倍，有效消除了运动模糊。这些性能提升得到了临床证据的支持。 2024年10月发表在《学术放射学》杂誌上的一项关于Cenomedical公司第二代Imagio乳房摄影成像系统的研究证实，该系统在区分良性和恶性肿瘤方面具有100%的灵敏度，凸显了将这些成像方式整合到常规临床实践中的潜力。

此外，慢性病（尤其是心血管疾病）发生率的上升，使得对非侵入性、无辐射诊断设备的需求日益增长。光声成像技术非常适合心血管疾病患者所需的频繁监测，因为它无需使用电离辐射即可绘製血氧饱和度图并识别血管异常。高死亡率进一步凸显了这项临床需求。根据美国疾病管制与预防中心 (CDC) 统计，2023 年美国有 919,032 人死于心血管疾病。随着医疗保健系统更加重视早期检测以降低死亡率，对能够同时提供功能和解剖数据的检测方式的需求不断增长，预计这将推动该技术在心血管领域的更广泛应用。

市场挑战

全球光声成像市场的主要阻碍因素是高昂的设备成本和缺乏完善的健保报销机制，这造成了巨大的经济障碍。此类混合系统所需的资本投入对于地方医院和私人诊所而言往往难以承受，这种经济负担极大地限制了目标市场。因此，该技术的应用仍集中在资金雄厚的研究机构，难以实现大规模临床应用，因此无法实现商业性规模化，也使其市场始终局限于小众领域而非大众市场。

此外，由于缺乏具体的报销代码，投资回报存在很大的不确定性。这令依赖保险支付营运成本的潜在买家望而却步。医疗影像领域本已面临预算限制，日益收紧的财务环境更加剧了这种犹豫。例如，美国放射学会 (ACR) 指出，根据联邦医疗保险医师收费标准 (PFS)，诊断放射学领域在 2024 年将面临约 4% 的报销削减。这种财务限制迫使医疗服务提供者优先考虑成熟的必要技术，而非新兴技术，从而有效地阻碍了光声成像技术的市场整合。

市场趋势

将人工智慧 (AI) 应用于影像重建以提高其准确性，正透过实现精确的定量分析和提升诊断准确率，彻底改变市场格局。深度学习演算法正被越来越多地用于提取量化生物标记的放射组学特征，从而克服传统重建方法在定性分析方面的局限性。这项进展在肿瘤学领域尤其重要，因为功能性见解对于指南治疗至关重要。一项发表于 2025 年 1 月《生物医学工程在线》(BioMedical Engineering Online) 的临床回顾性研究，纳入了 223 例乳癌患者，检验了基于光声技术的放射组学列线图在预测 Ki-67 表达水平方面的有效性，展现了其作为临床非侵入性分子表征技术的潜力。

同时，随着混合多模态影像平台的普及，这项技术的效用正从诊断影像扩展到治疗导引领域。製造商正在开发将光声成像与射频超音波和高强度聚焦超音波（HIFU）等治疗方式相结合的系统，从而在介入治疗过程中提供即时回馈。这些混合设备能够同时进行解剖定位和功能监测，并达到精准治疗。例如，在2025年9月出版的《雷射与光子学评论》（Laser & Photonics Reviews）上，研究人员详细介绍了一种配备20.0 MHz单元件换能器的双模系统。该系统结合了高解析度成像和治疗功能，有效地弥合了诊断筛检和影像引导治疗之间的差距。

目录

第一章概述

第二章：调查方法

第三章执行摘要

第四章：客户心声

第五章：全球光声成像市场展望

  • 市场规模及预测
    • 按金额
  • 市占率及预测
    • 产品细分（光声成像（PAT）、光声显微镜（PAM））
    • 按类型（临床前、临床）
    • 依应用领域（肿瘤学、心臟科、血管医学、组织学、介入放射学）
    • 按地区
    • 按公司（2025 年）
  • 市场地图

第六章：北美光声成像市场展望

  • 市场规模及预测
  • 市占率及预测
  • 北美洲：国别分析
    • 我们
    • 加拿大
    • 墨西哥

第七章：欧洲光声成像市场展望

  • 市场规模及预测
  • 市占率及预测
  • 欧洲：国别分析
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙

第八章：亚太地区光声成像市场展望

  • 市场规模及预测
  • 市占率及预测
  • 亚太地区：国别分析
    • 中国
    • 印度
    • 日本
    • 韩国
    • 澳洲

第九章：中东和非洲光声成像市场展望

  • 市场规模及预测
  • 市占率及预测
  • 中东与非洲：国别分析
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 南非

第十章：南美光声成像市场展望

  • 市场规模及预测
  • 市占率及预测
  • 南美洲：国别分析
    • 巴西
    • 哥伦比亚
    • 阿根廷

第十一章 市场动态

  • 促进因素
  • 任务

第十二章 市场趋势与发展

  • 併购
  • 产品发布
  • 近期趋势

第十三章：全球光声成像市场：SWOT分析

第十四章：波特五力分析

  • 产业竞争
  • 新进入者的潜力
  • 供应商的议价能力
  • 顾客权力
  • 替代品的威胁

第十五章 竞争格局

  • Seno Medical
  • FUJIFILM VisualSonics
  • iThera Medical
  • Endra Life Sciences
  • PixelLight
  • Optoacoustics
  • Canon Medical
  • Thermo Fisher
  • TomoWave
  • Advantest

第十六章 策略建议

第十七章：关于研究公司及免责声明

简介目录
Product Code: 25466

The Global Photoacoustic Imaging Market is projected to expand from USD 84.28 Million in 2025 to USD 153.51 Million by 2031, registering a CAGR of 10.51%. As a hybrid biomedical modality, this technology utilizes the photoacoustic effect to merge the high contrast of optical imaging with the deep tissue penetration capabilities of ultrasound. Growth in this sector is primarily fueled by the increasing prevalence of chronic diseases, specifically cancer and cardiovascular disorders, which necessitates non-invasive diagnostics capable of functional imaging. This demand is further amplified by the technology's capacity to map blood oxygenation and hemoglobin levels without utilizing ionizing radiation, a critical need given that the American Cancer Society projected 2,001,140 new cancer cases in the United States in 2024.

Market Overview
Forecast Period2027-2031
Market Size 2025USD 84.28 Million
Market Size 2031USD 153.51 Million
CAGR 2026-203110.51%
Fastest Growing SegmentPhotoacoustic Tomography (PAT)
Largest MarketNorth America

Despite these drivers, market growth faces significant obstacles due to the high costs associated with equipment and the technical complexity required for system operation. The substantial capital investment necessary for these dual-modality systems limits procurement largely to major research institutions, creating a financial barrier that excludes smaller clinical environments. Furthermore, the absence of established reimbursement codes for photoacoustic procedures creates a hurdle for widespread commercial adoption, restricting the integration of this technology into standard clinical workflows.

Market Driver

Technological breakthroughs in high-resolution hybrid imaging systems act as a major growth catalyst by resolving historical limitations regarding scan speed and image quality. Improvements in laser technology and ultrasound transducers now allow devices to deliver real-time functional insights with exceptional clarity. For example, in September 2024, researchers at University College London developed a handheld scanner capable of producing detailed 3D photoacoustic images 100 to 1,000 times faster than previous models, effectively eliminating motion-induced blurring. These performance enhancements are supported by clinical evidence; a study published in Academic Radiology in October 2024 regarding Seno Medical's second-generation Imagio Breast Imaging System reported an observed 100 percent sensitivity in distinguishing between benign and malignant masses, underscoring the feasibility of integrating these modalities into routine workflows.

Additionally, the increasing incidence of chronic conditions, especially cardiovascular diseases, drives the need for non-invasive and radiation-free diagnostic instruments. The ability of photoacoustic imaging to map blood oxygenation and identify vascular abnormalities without ionizing radiation makes it ideal for the frequent monitoring required for heart and vascular patients. This clinical necessity is emphasized by the heavy mortality burden, with the Centers for Disease Control and Prevention reporting that 919,032 individuals in the United States died from cardiovascular disease in 2023. As healthcare systems focus on early detection to reduce mortality rates, the demand for modalities providing both functional and anatomical data is set to rise, fostering broader adoption within cardiology and vascular departments.

Market Challenge

The primary factors restraining the Global Photoacoustic Imaging Market are the substantial financial barriers arising from high equipment costs and the lack of established reimbursement codes. This economic burden severely limits the addressable market, as the capital expenditure needed for such hybrid systems is often too high for community hospitals and private clinics to justify. As a result, adoption remains concentrated within well-funded research institutions, preventing the technology from reaching the high-volume clinical utilization required for widespread commercial scalability and keeping the market niche rather than mass-market oriented.

Moreover, the absence of specific reimbursement codes generates significant uncertainty regarding return on investment, which discourages potential buyers who depend on insurance payments to cover operational expenses. This hesitation is intensified by a tightening fiscal climate in the medical imaging sector, where budgets are already under pressure. For instance, the American College of Radiology noted that in 2024, diagnostic radiology faced an estimated reimbursement reduction of approximately 4% under the Medicare Physician Fee Schedule. Such financial constraints compel healthcare providers to favor essential, established modalities over emerging technologies, effectively stalling the market integration of photoacoustic imaging.

Market Trends

The integration of Artificial Intelligence for Enhanced Image Reconstruction is revolutionizing the market by facilitating precise quantitative analysis and elevating diagnostic accuracy. Deep learning algorithms are increasingly utilized to extract radiomic features that quantify biological markers, thereby transcending the qualitative limitations associated with traditional reconstruction methods. This advancement is particularly vital in oncology, where functional insights are essential for guiding treatment; a retrospective clinical study published in BioMedical Engineering OnLine in January 2025 involving 223 breast cancer patients validated a photoacoustic-based radiomic nomogram to predict Ki-67 expression levels, highlighting the technology's potential for non-invasive molecular characterization in clinical environments.

Simultaneously, the proliferation of hybrid multimodal imaging platforms is extending the utility of this technology beyond diagnostic imaging to include therapeutic guidance. Manufacturers are creating integrated systems that merge photoacoustic imaging with high-frequency ultrasound and therapeutic modalities, such as High-Intensity Focused Ultrasound (HIFU), to offer real-time feedback during interventions. These hybrid devices enable simultaneous anatomical mapping and functional monitoring to ensure precise treatment delivery. For example, researchers detailed in Laser & Photonics Reviews in September 2025 the introduction of a dual-mode system equipped with a single-element 20.0 MHz transducer capable of performing high-resolution imaging alongside therapeutic functions, effectively bridging the gap between diagnostic screening and image-guided therapy.

Key Market Players

  • Seno Medical
  • FUJIFILM VisualSonics
  • iThera Medical
  • Endra Life Sciences
  • PixelLight
  • Optoacoustics
  • Canon Medical
  • Thermo Fisher
  • TomoWave
  • Advantest

Report Scope

In this report, the Global Photoacoustic Imaging Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Photoacoustic Imaging Market, By Product

  • Photoacoustic Tomography (PAT)
  • Photoacoustic Microscopy (PAM)

Photoacoustic Imaging Market, By Type

  • Pre-Clinical
  • Clinical

Photoacoustic Imaging Market, By Application

  • Oncology
  • Cardiology
  • Angiology
  • Histology
  • Interventional radiology

Photoacoustic Imaging Market, By Region

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Photoacoustic Imaging Market.

Available Customizations:

Global Photoacoustic Imaging Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Photoacoustic Imaging Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Product (Photoacoustic Tomography (PAT), Photoacoustic Microscopy (PAM))
    • 5.2.2. By Type (Pre-Clinical, Clinical)
    • 5.2.3. By Application (Oncology, Cardiology, Angiology, Histology, Interventional radiology)
    • 5.2.4. By Region
    • 5.2.5. By Company (2025)
  • 5.3. Market Map

6. North America Photoacoustic Imaging Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Product
    • 6.2.2. By Type
    • 6.2.3. By Application
    • 6.2.4. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Photoacoustic Imaging Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Product
        • 6.3.1.2.2. By Type
        • 6.3.1.2.3. By Application
    • 6.3.2. Canada Photoacoustic Imaging Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Product
        • 6.3.2.2.2. By Type
        • 6.3.2.2.3. By Application
    • 6.3.3. Mexico Photoacoustic Imaging Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Product
        • 6.3.3.2.2. By Type
        • 6.3.3.2.3. By Application

7. Europe Photoacoustic Imaging Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Product
    • 7.2.2. By Type
    • 7.2.3. By Application
    • 7.2.4. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Photoacoustic Imaging Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Product
        • 7.3.1.2.2. By Type
        • 7.3.1.2.3. By Application
    • 7.3.2. France Photoacoustic Imaging Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Product
        • 7.3.2.2.2. By Type
        • 7.3.2.2.3. By Application
    • 7.3.3. United Kingdom Photoacoustic Imaging Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Product
        • 7.3.3.2.2. By Type
        • 7.3.3.2.3. By Application
    • 7.3.4. Italy Photoacoustic Imaging Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Product
        • 7.3.4.2.2. By Type
        • 7.3.4.2.3. By Application
    • 7.3.5. Spain Photoacoustic Imaging Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Product
        • 7.3.5.2.2. By Type
        • 7.3.5.2.3. By Application

8. Asia Pacific Photoacoustic Imaging Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Product
    • 8.2.2. By Type
    • 8.2.3. By Application
    • 8.2.4. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Photoacoustic Imaging Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Product
        • 8.3.1.2.2. By Type
        • 8.3.1.2.3. By Application
    • 8.3.2. India Photoacoustic Imaging Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Product
        • 8.3.2.2.2. By Type
        • 8.3.2.2.3. By Application
    • 8.3.3. Japan Photoacoustic Imaging Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Product
        • 8.3.3.2.2. By Type
        • 8.3.3.2.3. By Application
    • 8.3.4. South Korea Photoacoustic Imaging Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Product
        • 8.3.4.2.2. By Type
        • 8.3.4.2.3. By Application
    • 8.3.5. Australia Photoacoustic Imaging Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Product
        • 8.3.5.2.2. By Type
        • 8.3.5.2.3. By Application

9. Middle East & Africa Photoacoustic Imaging Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Product
    • 9.2.2. By Type
    • 9.2.3. By Application
    • 9.2.4. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia Photoacoustic Imaging Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Product
        • 9.3.1.2.2. By Type
        • 9.3.1.2.3. By Application
    • 9.3.2. UAE Photoacoustic Imaging Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Product
        • 9.3.2.2.2. By Type
        • 9.3.2.2.3. By Application
    • 9.3.3. South Africa Photoacoustic Imaging Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Product
        • 9.3.3.2.2. By Type
        • 9.3.3.2.3. By Application

10. South America Photoacoustic Imaging Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Product
    • 10.2.2. By Type
    • 10.2.3. By Application
    • 10.2.4. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Photoacoustic Imaging Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Product
        • 10.3.1.2.2. By Type
        • 10.3.1.2.3. By Application
    • 10.3.2. Colombia Photoacoustic Imaging Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Product
        • 10.3.2.2.2. By Type
        • 10.3.2.2.3. By Application
    • 10.3.3. Argentina Photoacoustic Imaging Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Product
        • 10.3.3.2.2. By Type
        • 10.3.3.2.3. By Application

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Photoacoustic Imaging Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Seno Medical
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. FUJIFILM VisualSonics
  • 15.3. iThera Medical
  • 15.4. Endra Life Sciences
  • 15.5. PixelLight
  • 15.6. Optoacoustics
  • 15.7. Canon Medical
  • 15.8. Thermo Fisher
  • 15.9. TomoWave
  • 15.10. Advantest

16. Strategic Recommendations

17. About Us & Disclaimer